LexaGene in Forbes: Positioned to fight coronavirus pandemic
Forbes profile on LexaGene’s technology: ‘It’s hard to imagine a startup better positioned to respond to the coronavirus pandemic than Beverly, Massachusetts-based LexaGene.’
Dr. Regan quoted in Boston Herald
Dr. Jack Regan, CEO and Founder of LexaGene quoted in Boston Herald article on the potential resurgence of COVID-19 in the fall.
LexaGene featured in Clinical Lab Products
LexaGene featured in Clinical Lab Products: “LexaGene responds to demand for better diagnostics for COVID-19.”
LexaGene talks COVID with Boston Herald
LexaGene featured in Boston Herald: “Testing for the coronavirus could be done in an hour without lab-trained technicians using a device the size of a Keurig coffee machine that a Boston-area biotech company is developing.”
LexaGene on ABC News
LexaGene featured on ABC affiliate WCVB News Boston on how the company plans to help with better testing for the rapid detection of COVID-19.
LexaGene in New York Times
LexaGene mentioned in New York Times article focusing on genomic testing efforts to combat COVID-19.
LexaGene mentioned in Forbes on COVID-19
LexaGene CEO Dr. Jack Regan mentioned in Forbes article on the potential infection rate of COVID-19 and worldwide impact.
LexaGene local coverage: Coronavirus
Read local coverage of LexaGene’s development of a genetic analyzer to detect viruses like coronavirus.
Coronavirus news recap
LexaGene CEO and Founder Dr. Jack Regan explains the threat of the current coronavirus outbreak and recaps LexaGene’s latest news describing the company’s role in preventing the spread of pathogens like coronavirus.
Cleanroom Technology article
Shortcomings in traditional culture testing leave the cannabis industry in search of methods that can enumerate or count the presence of microbes whether dead or alive. LexaGene CEO Dr. Jack Regan presents an alternative in the Cleanroom Technology article on LexaGene’s DNA-driven pathogen detection for cannabis-hemp products.
Forbes features LexaGene: Next big breakthrough
This Forbes full-length feature on LexaGene and our technology describes how LexaGene could be the next big medical breakthrough. > Read now.
LexaGene introduced in Forbes
LexaGene was mentioned in this Forbes article as a solution provider tackling the challenge of improving food safety and reducing recalls.